{
  "drug_name": "Levocarnitine",
  "url": "https://wikem.org/wiki/Levocarnitine",
  "scraped_at": "2026-01-10T07:56:25.399135",
  "sections": {
    "Administration": {
      "text": "Type: amino-acid derivative,\nAntidote\nDosage Forms: Capsule 250mg, 330mg; Solution (PO) 1g/10mL; Solution (IV) 200mg/mL\nRoutes of Administration: IV, oral\nCommon Trade Names: Carnitor",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Antidote",
          "url": "https://wikem.org/wiki/Antidote"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "Valproic acid toxicity\n: 100mg/kg IV bolus, followed by 50mg/kg Q8h or alternatively 50mg/kg/day IV in 3 divided doses\nPrimary carnitine deficiency: 990mg tablet or 1g solution PO 1-3 times per day\nCarnitine deficiency due to inborn error of metabolism\nInitial: 50 mg/kg (max 300mg) IV bolus, repeat daily PRN\nSevere metabolic crisis: 50 mg/kg IV (max 300mg) IV bolus, then repeat 50mg/kg IV over 24h in divided doses. Repeat 50mg/kg IV daily PRN.\n990mg tablet or 1g solution PO 1-3 times per day\nCarnitine deficiency due to ESRD: 10 to 20 mg/kg (dry weight) after HD, subsequent dosing determent by pre-HD levels of levocarnitine",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Valproic acid toxicity",
          "url": "https://wikem.org/wiki/Valproic_acid_toxicity"
        }
      ]
    },
    "Pediatric_Dosing": {
      "text": "IV dosing: same as adult dosing\nPO dosing: 50 mg/kg PO",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: B\nLactation risk\n: Infant risk cannot be ruled out\nRenal dosing: dosing not established, may be more prone to accumulation of toxic metabolites\nHepatic dosing: no adjustment",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        },
        {
          "text": "Lactation risk",
          "url": "https://wikem.org/wiki/Lactation_risk_categories"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Seizure",
          "tables": []
        },
        "Common": {
          "text": "Nausea/vomiting, diarrhea, stomach cramps",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Serious": {
      "text": "Seizure",
      "subsections": {
        "Common": {
          "text": "Nausea/vomiting, diarrhea, stomach cramps",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Common": {
      "text": "Nausea/vomiting, diarrhea, stomach cramps",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 17.4h\nMetabolism: Hepatic\nExcretion: Mostly renal",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Amino-acid found normally in humans: facilitates entry of long-chain fatty acids into cellular mitochondria\nIncreases valproate metabolism",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "Antidotes\nValproic acid toxicity\nInborn errors of metabolism",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Antidotes",
          "url": "https://wikem.org/wiki/Antidotes"
        },
        {
          "text": "Valproic acid toxicity",
          "url": "https://wikem.org/wiki/Valproic_acid_toxicity"
        },
        {
          "text": "Inborn errors of metabolism",
          "url": "https://wikem.org/wiki/Inborn_errors_of_metabolism"
        }
      ]
    }
  }
}